Boehringer Ingelheim plans sustainability work for the long term
Frameworks for environmental, social, and governance (ESG) reporting across sectors have long been focused on environmental sustainability, with plans that…
Frameworks for environmental, social, and governance (ESG) reporting across sectors have long been focused on environmental sustainability, with plans that…
US-based 2seventy bio has completed an asset purchase agreement (APA) to divest its haemophilia A candidate to Novo Nordisk. 2seventy…
Cancer-focused biotech Ability Biologics has announced the close of an $18m seed funding extension round. The Canadian biotech uses its…
Analytics firm Target RWE has published its findings that 99% of participants in TARGET-NASH, a research registry of patients with…
Cancer-focused biotech Tacalyx has extended its seed financing round to raise over €14m ($15.03m). The German biotech has established a…
France-headquartered Ipsen has expanded its ongoing oncology research partnership with Marengo Therapeutics to advance precision T cell engagers (TCE) using…
The US Food and Drug Administration (FDA) has criticised the state of Chinese pharma company Jiangsu Hengrui’s facilities in a…
An Italian anti-trust regulator has launched an anti-competition probe into Samsung Bioepis, Genentech, Novartis, Biogen, and some of the companies…
Belgian biotech, Bio-Sourcing, and Cape Town based company, Afrigen Biologics, have signed a partnership for a technology transfer pilot programme…
Monday saw a 9% drop in GlaxoSmithKline’s (GSK) share price on the London Stock Exchange (LSE), following a Delaware judge’s…